Tianning Gu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacy.
Journal: Nature cancer
Published: July 12, 2025
How can we improve the successful identification of patients suitable for CAR-T cell therapy?
Journal: Expert review of molecular diagnostics
Published: September 11, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
Journal: The New England journal of medicine
Published: April 24, 2024
MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-Fos and JunB.
Journal: Signal transduction and targeted therapy
Published: November 27, 2023
Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation.
Journal: Cell metabolism
Published: May 01, 2023
Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches.
Journal: Journal of Zhejiang University. Science. B
Published: October 13, 2022
Hydrogel-based microenvironment engineering of haematopoietic stem cells.
Journal: Cellular and molecular life sciences : CMLS
Published: August 09, 2022
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting.
Journal: Experimental hematology & oncology
Published: August 05, 2022
Hematologic cytopenia post CAR T cell therapy: Etiology, potential mechanisms and perspective.
Journal: Cancer letters
Published: July 07, 2022
CAR T-cell therapies in China: rapid evolution and a bright future.
Journal: The Lancet. Haematology
Published: January 31, 2022
Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
Journal: Frontiers in immunology
Published: September 29, 2021
Last Updated: 09/26/2026